Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · IEX Real-Time Price · USD
1.520
+0.030 (2.01%)
At close: Apr 23, 2024, 4:00 PM
1.600
+0.080 (5.26%)
Pre-market: Apr 24, 2024, 4:50 AM EDT
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $193.78 million as of April 24, 2024. Its market cap has decreased by -50.59% in one year.
Market Cap
193.78M
Enterprise Value
43.05M
1-Year Change
-50.59%
Ranking
Category
Stock Price
$1.52
Market Cap Chart
Since November 3, 2021, Compass Therapeutics's market cap has decreased from $219.00M to $193.78M, a decrease of -11.52%. That is a compound annual growth rate of -4.84%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 22, 2024 | 205.00M | 1.33% |
Apr 19, 2024 | 202.30M | -1.32% |
Apr 18, 2024 | 205.00M | -2.61% |
Apr 17, 2024 | 210.50M | -2.55% |
Apr 16, 2024 | 216.00M | -0.64% |
Apr 15, 2024 | 217.40M | -2.47% |
Apr 12, 2024 | 222.90M | 1.27% |
Apr 11, 2024 | 220.10M | - |
Apr 10, 2024 | 220.10M | -4.22% |
Apr 9, 2024 | 229.80M | -1.75% |
Apr 8, 2024 | 233.90M | - |
Apr 5, 2024 | 233.90M | -2.30% |
Apr 4, 2024 | 239.40M | -5.93% |
Apr 3, 2024 | 254.50M | 2.75% |
Apr 2, 2024 | 247.70M | -2.17% |
Apr 1, 2024 | 253.20M | -7.05% |
Mar 28, 2024 | 272.40M | -3.44% |
Mar 27, 2024 | 282.10M | 3.56% |
Mar 26, 2024 | 272.40M | -3.44% |
Mar 25, 2024 | 282.10M | -3.75% |
Mar 22, 2024 | 293.10M | -4.90% |
Mar 21, 2024 | 308.20M | 14.02% |
Mar 20, 2024 | 270.30M | -0.92% |
Mar 19, 2024 | 272.80M | -4.88% |
Mar 18, 2024 | 286.80M | -1.75% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly | 709.13B |
Novo Nordisk | 559.76B |
UnitedHealth Group | 448.47B |
Johnson & Johnson | 360.36B |
Merck & Co. | 321.39B |
AbbVie | 300.16B |
AstraZeneca | 219.62B |
Thermo Fisher | 219.52B |